The U.S. virtual care market size was exhibited at USD 9.15 billion in 2024 and is projected to hit around USD 151.0 billion by 2034, growing at a CAGR of 32.36% during the forecast period 2025 to 2034.
Report Coverage | Details |
Market Size in 2025 | USD 12.11 Billion |
Market Size by 2034 | USD 151.0 Billion |
Growth Rate From 2025 to 2034 | CAGR of 32.36% |
Base Year | 2024 |
Forecast Period | 2025-2034 |
Segments Covered | Consultation Mode and Application |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Key Companies Profiled | CVS Health; virtuwell.com.; MeMD; HealthTap, Inc.; iCliniq; Teladoc Health Inc.; American Well; MDLIVE; Doctor On Demand; Sesame, Inc. |
The lack of primary care physicians and healthcare specialists in the U.S. is one of the major factors expected to accelerate the market growth in the U.S. For instance, as per the Association of American Medical Colleges (AAMC) estimates, the U.S. is expected to face a shortage of between 37,800 and 124,000 physicians by 2034, including a shortage of primary and specialty physicians. In addition, the widespread adoption of digital technologies is fueling the market growth.
The rise in the prevalence of chronic diseases necessitates a proactive approach to healthcare management. Virtual care platforms and solutions leverage technology to better monitor, communicate, and engage patients and healthcare providers. These solutions facilitate personalized care plans and remote patient monitoring. As healthcare organizations recognize the importance of addressing the needs of an aging population with chronic illnesses, the demand for innovative virtual care platforms is expected to grow over the forecast period. For instance, market players such as Caregility, HealthSnap , Inc., and Aetonix Systems provide virtual care platforms for chronic disease management.
The U.S. government is making massive investments in digital health and boosting healthcare IT and virtual care platform adoption, which is expected to stimulate market growth. According to Rock Health's annual year-end funding report U.S. digital health startups raising USD 10.7 billion across 492 deals in 2023.
Moreover, in February 2021, the United States Department of Agriculture (USDA) spent USD 42 million on telemedicine infrastructure and remote learning to improve health outcomes and education. Through the Distance Learning and Telemedicine (DLT) program, the USDA financed 86 projects in rural regions to help individuals by offering healthcare education and grants to purchase telemedicine interactive telecommunications distance learning technology.
Furthermore, market players are adopting various strategies such as mergers and acquisitions, partnerships and collaborations, new service launches, and geographical expansion to capture a larger market share. For instance, in May 2022, CVS Health introduced CVS Health Virtual Primary Care, a new virtual care solution to enhance primary care through virtual or at-home health services available through a single digital platform.
By consultation mode, the audio segment in U.S. virtual care market held the largest revenue share of 46.0% in 2024. Easy access and a higher preference for phone calls drive the segment growth. Moreover, many people reside on the side of the digital divide, where access to technology and high-speed internet service is limited. For instance, according to an article published in Mayo Clinic Proceedings: Digital Health journal in September 2023, over 21 million individuals in the U.S. live in "digital deserts" (without broadband access). Both rural and urban residents are affected by this issue. For these individuals, audio-only visits have proven to be a successful means of overcoming barriers to care, such as mobility issues, lack of transportation, and lack of nearby providers.
Moreover, audio-only consultations have expanded access to crucially needed behavioral health services. For example, Call 4 Health, ALL, a virtual consultation company in the U.S., provides audio call services for health consultations.
The video segment is anticipated to witness the fastest CAGR growth over the forecast period. Virtual care encompasses phone and message consultations, and the frequency of telehealth appointments conducted by video has risen dramatically. For instance, a Telehealth Satisfaction Study conducted by The J.D. Power reported that 67% of surveyed individuals in the U.S. accessed video services in 2022. Thus, the rise in the adoption of video consultation services boosts the segment growth.
By application, the family medicine segment in U.S. virtual care market held the largest revenue share of 29.6% in 2024. A high number of online consultations for acute and primary care is the main factor driving the segment's growth. For instance, Virtual Care for Families, a U.S.-based digital health company, provides personalized virtual care from the comfort of users' homes and develops a custom treatment plan. Moreover, the American Academy of Family Physicians (AAFP) recommends expanding the use of telemedicine as an efficient and appropriate means of enhancing health when handled by adequate standards of care. Thus, increasing adoption of virtual care by family physicians is expected to fuel the segment's growth.
The others segment is anticipated to witness the fastest CAGR over the forecast period. The others segment comprises gastroenterology, gynecology, and psychiatry services. Shifting trends from traditional care methods to patient-centric and personalized care support adopting virtual care platforms. For instance, in September 2024, Iris Telehealth, a provider of transformative behavioral health services, introduced the Iris Insights and Virtual Clinic platforms to integrate behavioral healthcare into their patient journeys seamlessly.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the U.S. virtual care market
By Consultation Mode
By Application
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Consultation mode outlook
2.2.2. Application outlook
2.3. Competitive Insights
Chapter 3. U.S. Virtual Care Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. U.S. Virtual Care: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
3.4. Technology Timeline Analysis: Emerging Trends
3.5. Case Study Analysis
Chapter 4. U.S. Virtual Care Market Segment Analysis, By Consultation Mode, 2018-2030 (USD Million)
4.1. Definition and Scope
4.2. Consultation Mode Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. U.S. Virtual Care Market, by Consultation Mode, 2018 to 2030
4.5. Audio
4.5.1. Audio market estimates and forecasts 2018 to 2030, (USD Million)
4.6. Messaging
4.6.1. Messaging market estimates and forecasts 2018 to 2030, (USD Million)
4.7. Video
4.7.1. Video market estimates and forecasts 2018 to 2030, (USD Million)
Chapter 5. U.S. Virtual Care Market Segment Analysis, By Application, 2018-2030 (USD Million)
5.1. Definition and Scope
5.2. Application Market Share Analysis, 2024 & 2030
5.3. Segment Dashboard
5.4. U.S. Virtual Care Market, by Application, 2018 to 2030
5.5. Family Medicine
5.5.1. Family Medicine market estimates and forecasts, 2018 to 2030 (USD million)
5.6. Internal Medicine
5.6.1. Internal Medicine market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Cardiology
5.7.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Pediatrics
5.8.1. Pediatrics market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Endocrionology
5.9.1. Endocrionology market estimates and forecasts, 2018 to 2030 (USD Million)
5.10. Rheumatology
5.10.1. Rheumatology market estimates and forecasts, 2018 to 2030 (USD Million)
5.11. Pulmonology
5.11.1. Pulmonology market estimates and forecasts, 2018 to 2030 (USD Million)
5.12. Others
5.12.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company Categorization
6.3. Company Profiles
6.3.1. CVS Health
6.3.1.1. Company overview
6.3.1.2. Financial performance
6.3.1.3. Product benchmarking
6.3.1.4. Strategic initiatives
6.3.2. virtuwell.com.
6.3.2.1. Company overview
6.3.2.2. Financial performance
6.3.2.3. Product benchmarking
6.3.2.4. Strategic initiatives
6.3.3. MeMD
6.3.3.1. Company overview
6.3.3.2. Financial performance
6.3.3.3. Product benchmarking
6.3.3.4. Strategic initiatives
6.3.4. HealthTap, Inc.
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. iCliniq
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. Teladoc Health Inc.
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. American Well
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. MDLIVE
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. Doctor on Demand
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Sesame, Inc.
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives